Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Heron Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 171 | 2 | 172 | +3 |
| Shares | 131.5M | 60.4K | 152.7M | +21.3M (+16.2%) |
| Value | $272.1M | $125.1K | $192.4M | −$79.6M (−29.3%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Heron Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 4,251,951 | $5.36M | 0.04% |
| Caption Management, LLC | 734,297 | $925.2K | 0.05% |
| Pale Fire Capital SE | 471,190 | $593.7K | 0.07% |
| Connor, Clark & Lunn Investment Management Ltd. | 83,695 | $105.5K | 0.00% |
| Ieq Capital, LLC | 79,025 | $99.6K | 0.00% |
| Cerity Partners LLC | 51,712 | $65.2K | 0.00% |
| Mariner, LLC | 35,899 | $45.2K | 0.00% |
| SRS Capital Advisors, Inc. | 33,374 | $42.1K | 0.00% |
| XTX Topco Ltd | 30,497 | $38.4K | 0.00% |
| Voleon Capital Management LP | 26,940 | $33.9K | 0.00% |
| Mercer Global Advisors Inc | 26,709 | $33.7K | 0.00% |
| PKS Advisory Services, LLC | 20,000 | $25.2K | 0.01% |
| Colony Group, LLC | 18,615 | $23.5K | 0.00% |
| CIBC Bancorp USA Inc. | 16,307 | $20.5K | 0.00% |
| AE Wealth Management LLC | 14,651 | $18.5K | 0.00% |
| HBK Sorce Advisory LLC | 10,000 | $13.5K | 0.00% |
| Advisory Services Network, LLC | 760 | $958 | 0.00% |
| Financial Consulate, Inc | 500 | $630 | 0.00% |
| Rockefeller Capital Management L.P. | 61 | $77 | 0.00% |
Sold out (16)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| AIGH Capital Management LLC | 3,009,257 | $6.23M |
| Jacobs Levy Equity Management, Inc | 820,504 | $1.70M |
| Jefferies Financial Group Inc. | 666,800 | $1.38M |
| TD Asset Management Inc | 394,600 | $816.8K |
| Qube Research & Technologies Ltd | 132,782 | $274.9K |
| State Board of Administration of Florida Retirement System | 26,894 | $55.7K |
| Brevan Howard Capital Management LP | 19,806 | $41.0K |
| Zacks Investment Management | 14,899 | $30.8K |
| Capital Investment Counsel, Inc | 14,625 | $30.3K |
| Two Sigma Securities, LLC | 14,376 | $29.8K |
| Moors & Cabot, Inc. | 11,250 | $23.3K |
| Nisa Investment Advisors, LLC | 1,456 | $3.01K |
| Skopos Labs, Inc. | 364 | $754 |
| True Wealth Design, LLC | 330 | $684 |
| The PNC Financial Services Group, Inc. | 173 | $358 |
| Mid-American Wealth Advisory Group, Inc. | 24 | $50 |
Not filed for Q3 2025 yet (2)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Horan Securities, Inc. | 41,590 | $86.1K |
| CIBC World Markets Corp | 18,848 | $39.0K |